- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vetoquinol (VETO)
The Vetoquinol share price today is 73.00, view EPA VETO stock exchange data. Track the latest Vetoquinol share price with real-time updates on VETO stock performance including market cap, day range, 52-week range and dividend yield. Access VETO charts, earnings dates and analyst estimates to support your investment decisions.
73.00
+0.30(+0.41%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
72.80
74.20
52 wk Range
67.20
91.50
VETO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
72.8074.20
52 wk Range
67.2091.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VETO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
90.38
Upside
+23.80%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Vetoquinol: 2025 Calendar of Financial Communication- Investing.com
Vetoquinol: Sales at End September 2024- Investing.com
- Vetoquinol Group: Sales for 1st Quarter 2025
- Investing.com
- Vetoquinol Group: Sales for 1st Quarter 2025
- Investing.com
Vetoquinol: Annual Results 2024- Investing.com
Vetoquinol: Annual Sales 2024- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 90.38
(+23.80% Upside)
Earnings
Latest Release
28-04-2026
EPS / Forecast
-- / --
Revenue / Forecast
125M / --
Compare VETO to Peers and Sector
Metrics to compare | VETO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVETOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.8x | 15.0x | −0.3x | |
PEG Ratio | −18.54 | 0.34 | 0.00 | |
Price/Book | 1.4x | 2.3x | 2.6x | |
Price / LTM Sales | 1.6x | 3.3x | 3.0x | |
Upside (Analyst Target) | 17.5% | 14.7% | 56.3% | |
Fair Value Upside | Unlock | 8.6% | 9.2% | Unlock |
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Vetoquinol (VETO) Share Price Today?
The Vetoquinol share price today is 73.00.
What is the current Vetoquinol (VETO) share price and day range?
As of 02-08-2026, the Vetoquinol share price is 73.00, with a previous close of 72.70. The share price has ranged from 72.80 to 74.20 today, while the 52-week range spans from 67.20 to 91.50.
What Is the Vetoquinol Market Cap?
As of today, Vetoquinol market cap is 848.41M.
Does Vetoquinol Pay Dividends? What's The Current Dividend Yield?
The Vetoquinol dividend yield is 1.28%.
What Is the Vetoquinol (VETO) Share Price Target?
The average 12-month share price target for Vetoquinol is 90.38, with a high estimate of 110 and a low estimate of 80. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +23.80% Upside potential.
What Is Vetoquinol's Earnings Per Share (TTM)?
The Vetoquinol EPS (TTM) is 4.94.
When Is the Next Vetoquinol Earnings Date?
Vetoquinol will release its next earnings report on 11-09-2026.
From a Technical Analysis Perspective, Is VETO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Vetoquinol Trade On?
Vetoquinol is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Vetoquinol?
The stock symbol for Vetoquinol is "VETO."
How Many Times Has Vetoquinol Stock Split?
Vetoquinol has split 0 times.
How Many Employees Does Vetoquinol Have?
Vetoquinol has 2454 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.